Hepatitis B surface antigen
SpainMedications containing this active substance
-
Engerix-B 20 micrograms/1 ml, suspension for injection in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage Hepatitis B surface antigen 20 µg Manufacturer: Glaxosmithkline S.A.
-
Engerix-B Junior 10 micrograms/0.5 ml, suspension for injection in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage Hepatitis B surface antigen 10 µg Manufacturer: Glaxosmithkline S.A.
-
Fendrix, injectable suspension
Form: suspension for injection, in pre-filled syringe
Active substance Dosage Hepatitis B surface antigen 20 µg Manufacturer: Glaxosmithkline Biologicals
-
HBVaxPro 10 micrograms, injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage Hepatitis B surface antigen 10 µg Manufacturer: Merck Sharp & Dohme B.V.
-
HBVaxPro 40 micrograms, injection suspension
Form: suspension for injection
Active substance Dosage Hepatitis B surface antigen 0,04 mg Manufacturer: Merck Sharp & Dohme B.V.
-
HBVaxPro 5 micrograms, suspension for injection in pre-filled syringe
Form: suspension for injection
Active substance Dosage Hepatitis B surface antigen 5 µg Manufacturer: Merck Sharp & Dohme B.V.
-
Hexyon injectable suspension in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage TETANUS TOXOID 40 UI Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 40 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 8 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg H. INFLUENZAE TYPE B POLYSACCHARIDE TETANUS TOXOID CONJUGATE 12 µg DIPHTHERIA TOXOID 20 UI Manufacturer: Sanofi Winthrop Industrie
-
Hexyon injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage DIPHTHERIA TOXOID 20 UI TETANUS TOXOID 40 UI Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 40 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 8 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP 12 µg Manufacturer: Sanofi Winthrop Industrie
-
Hexyon injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage DIPHTHERIA TOXOID 20 UI TETANUS TOXOID 40 UI Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 40 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 8 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE PRP 12 µg Manufacturer: Sanofi Winthrop Industrie
-
Infanrix Hexa powder and suspension for suspension for injection
Form: powder and solvent for injectable suspension
Active substance Dosage DIPHTHERIA TOXOID 30 UI TETANUS TOXOID 40 UI H. INFLUENZAE TYPE B POLYSACCHARIDE TETANUS TOXOID CONJUGATE 0,02 mg HAEMOPHILUS INFLUENZAE TYPE B 0,01 mg Bordetella pertussis toxoid 0,025 mg Bordetella pertussis filamentous hemagglutinin 0,025 mg Bordetella pertussis 69 kD outer membrane protein 0,01 mg POLIOVIRUS TYPE I 40 U.D. (UNIDADES ANTIGENICAS D) POLIOVIRUS TYPE II 8 U.D. (UNIDADES ANTIGENICAS D) POLIOVIRUS TYPE III 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 0,01 mg Manufacturer: Glaxosmithkline Biologicals
-
Infanrix Hexa powder and suspension for suspension for injection
Form: powder and solvent for injectable suspension
Active substance Dosage DIPHTHERIA TOXOID 30 UI TETANUS TOXOID 40 UI H. INFLUENZAE TYPE B POLYSACCHARIDE TETANUS TOXOID CONJUGATE 20 µg HAEMOPHILUS INFLUENZAE TYPE B 10 µg Bordetella pertussis toxoid 25 µg Bordetella pertussis filamentous hemagglutinin 25 µg Bordetella pertussis 69 kD outer membrane protein 10 µg POLIOVIRUS TYPE I 40 U.D. (UNIDADES ANTIGENICAS D) POLIOVIRUS TYPE II 8 U.D. (UNIDADES ANTIGENICAS D) POLIOVIRUS TYPE III 32 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg Manufacturer: Glaxosmithkline Biologicals
-
Twinrix Adults, injectable suspension in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage Hepatitis A antigen 720 U ELISA Hepatitis B surface antigen 20 µg Manufacturer: Glaxosmithkline Biologicals
-
Twinrix Pediatric, injectable suspension in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage Hepatitis A antigen 360 U ELISA Hepatitis B surface antigen 10 µg Manufacturer: Glaxosmithkline Biologicals
-
Vaxelis injectable suspension in pre-filled syringe
Form: suspension for injection, in pre-filled syringe
Active substance Dosage DIPHTHERIA TOXOID Mayor o igual a 20 UI TETANUS TOXOID Mayor o igual a 40 UI Bordetella pertussis toxoid 20 µg Bordetella pertussis filamentous hemagglutinin 20 µg Bordetella pertussis pertactin 3 µg Pertussis fimbriae agglutinogen toxoid 5 µg INACTIVATED POLIOVIRUS TYPE 1 MAHONEY PRODUCED IN VERO CELLS 29 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 2 MEF-1 PRODUCED IN VERO CELLS 7 U.D. (UNIDADES ANTIGENICAS D) INACTIVATED POLIOVIRUS TYPE 3 SAUKETT PRODUCED IN VERO CELLS 26 U.D. (UNIDADES ANTIGENICAS D) Hepatitis B surface antigen 10 µg CONJUGATE HAEMOPHILUS INFLUENZAE PRP-NEISSERIA MENINGITIDIS OMPC 3 µg Manufacturer: Mcm Vaccine B.V.